Cargando…
Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study
Autores principales: | Blaha, V, Margoczy, R, Petrov, I, Postadzhiyan, A, Raslova, K, Rosolova, H, Bridges, I, Dhalwani, NN, Zachlederova, M, Ray, KK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316339/ https://www.ncbi.nlm.nih.gov/pubmed/37405342 http://dx.doi.org/10.15420/ecr.2023.18.PO19 |
Ejemplares similares
-
Oral Presentation Award Winner: LDL-C Reduction in Diabetic Patients after Percutaneous Coronary Intervention: Is There any Difference with Non-diabetic?
por: Mallofré, N, et al.
Publicado: (2023) -
HDL Mimetics Enhances Mitochondrial Function via Stimulation of PGC1-α
por: Zhang, Hang, et al.
Publicado: (2023) -
Use of Heart Failure-Exacerbating Medications among Heart Failure Patients in a Tertiary Referral Centre in Malaysia
por: Wong, Yii Ching
Publicado: (2023) -
Evaluating the Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation following Coronary Artery Bypass Graft Surgery: A Randomised Controlled Trial
por: Dastan, Farzaneh, et al.
Publicado: (2023) -
Difficulties in Monitoring Antithrombotic Therapy in Patients with Atrial Fibrillation and Post-traumatic Hepatic and Splenic Visceral Haematomas
por: Beznă, Maria Cristina, et al.
Publicado: (2023)